Search Results - "Burns, Tammy L."

Impact of a blood conservation program on 30-day morbidity and mortality: a cohort study by Ramanan, Bala, MBBS, Burns, Tammy L., PharmD, Sugimoto, Jeffrey T., MD, Forse, Robert Armour, MD, PhD

“…Abstract Background There are little published data on outcomes of blood conservation (BC) patients after noncardiac surgery. The objective of this study was…”
Get full text

Reducing the Risk of Obesity: Defining the Role of Weight Loss Drugs by Ling, Hua, Lenz, Thomas L., Burns, Tammy L., Hilleman, Daniel E.

“…The prevalence of obesity has increased dramatically in the past 20 years. As a public health concern, obesity is associated with a health care resource burden…”
Get full text

An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents for lowering low-density lipoprotein cholesterol by Ling, Hua, Burns, Tammy L, Hilleman, Daniel E

“…Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays an essential role in the degradation of low-density lipoprotein C (LDL-C) receptors, and PCSK9…”
Get more information

Novel Strategies for Managing Dyslipidemia: Treatment beyond Statins by Ling, Hua, Burns, Tammy L., Hilleman, Daniel E.

“…Purpose: This article reviews the current status of lipid-lowering drugs and their impact on cardiovascular morbidity and mortality. Because there is…”
Get full text

Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain by Burns, Tammy L, Ineck, Joseph R

“…Objective: To review the literature concerning the physiology of the endocannabinoid system, current drug development of cannabinoid agonists, and current…”
Get full text

Impact of Ranolazine on Clinical Outcomes and Healthcare Resource Utilization in Patients with Refractory Angina Pectoris by Ling, Hua, Packard, Kathleen A., Burns, Tammy L., Hilleman, Daniel E.

“…Background Ranolazine is a novel antianginal medication approved for the treatment of chronic angina. There are only limited data concerning the efficacy of…”
Get full text

Efficacy and safety of transulnar coronary angiography and interventions-A single center experience by Deshmukh, Anand R., Kaushik, Manu, Aboeata, Ahmed, Abuzetun, Jamil, Burns, Tammy L., Nubel, Caroline A., White, Michael D., Lanspa, Thomas J., Hunter, Claire B., Mooss, Aryan N., Esterbrooks, Dennis J.

“…Objectives To evaluate the efficacy and long‐term safety of transulnar approach in complex coronary interventions. Background The success rate of transulnar…”
Get full text

Evaluation of an adult insulin infusion protocol at an academic medical center by Petrov, Katerina I, Burns, Tammy L, Drincic, Andjela

“…Acknowledging evidence of possible detrimental effects of tightly controlled blood glucose levels, the American Association of Clinical Endocrinologists and…”
Get full text

Improvement in Appropriate Utilization of Recombinant Human Erythropoietin Pre- and Post-Implementation of a Required Order Form by Burns, Tammy L, Ferry, Brenna A, Malesker, Mark A, Morrow, Lee E, Bruckner, Anne L, Lee, Debra L

“…BACKGROUND: Erythropoietin stimulating agents (ESAs) are high-cost medications that have a significant impact on many pharmacy budgets. Recently, ESAs have…”
Get full text

Current State of United States Tobacco Control Initiatives by Burns, Tammy L., Ruckman, Jilyan A., Ling, Hua, Washington-Krauth, Shavonne M., Hilleman, Daniel E., Mohiuddin, Syed M.

“…Reduction of tobacco use around the world is a high priority. This review will provide the current status of tobacco control with particular focus on progress…”
Get full text

Aliskiren in Patients Failing to Achieve Blood Pressure Targets With Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers by Hawkins, Elizabeth B, Ling, Hua, Burns, Tammy L, Mooss, Aryan N, Hilleman, Daniel E

“…To assess the efficacy of aliskiren in patients failing to reach blood pressure (BP) goals with angiotensin converting enzyme inhibitor (ACEI) or angiotensin…”
Get full text

Antiplatelet Drug Resistance: Not Ready for Prime Time by Burns, Tammy L., Mooss, Aryan N., Hilleman, Daniel E.

“…Antiplatelet drug therapy reduces vascular events in a wide range of patients. Although antiplatelet drug resistance is becoming well documented, a universal…”
Get full text

Reducing the Risk of Obesity: Defining the Role of Weight Loss Drugs : OBESITY by HUA LING, LENZ, Thomas L, BURNS, Tammy L, HILLEMAN, Daniel E

Get full text

COST-EFFECTIVENESS OF INTENSIVE INSULIN THERAPY IN CRITICALLY ILL PATIENTS: A META-ANALYSIS: 115-M by Malesker, Mark A, Morrow, Lee E, Burns, Tammy L, Hilleman, Daniel E

Get full text

Cost-Effectiveness of Glycoprotein IIb/IIIa Inhibitors in Diabetics with Non-STEMI ACS by Hilleman, Daniel E, Burns, Tammy L, Knudsen, Dawn, Maciejewski, Stephanie R, Reyes, Antonio P

Get full text

Cost-Effectiveness of Intensive Insulin Therapy in Critical Illness: Literature Review and Meta-Analysis by Hilleman, Daniel E, Burns, Tammy L, Monaghan, Michael S, Stading, Julie A, Skrabel, Maryann Z

Get full text

Book Review: Fundamentals of Musculoskeletal Pain by Graven-Nielsen, Thomas, Arendt-Nielsen, Lars, Mense, Siegfried, Burns, Tammy L

Get full text

Book Review: Pharmacology of Pain by Burns, Tammy L

Get full text